Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Chengdu Tianyin Pharma Completes Reverse Merger

publication date: Jan 18, 2008

Chengdu Tianyin Pharmaceutical Co. Ltd. effected a reverse merger with VisCorp (OTCBB: VSCO) on January 16, and at the same time, the company announced that it had successfully raised $10.2 million in a private placement. Tianyin Pharmaceutical Co., Inc. will become the new name of the company. Chengdu Tianyin, which was founded in 1994, manufactures traditional China medicines and other pharmaceuticals. In fiscal 2007, which ended June 30, 2007, Chengdu Tianyin reported revenues of $20.4 million and net income of $4.2 million. More details...

Stock Symbol: (OTCBB: VSCO)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here